Cost Effectiveness of Preoperative Screening for Healthy Patients Undergoing Robotic Hysterectomy
Leadership and Advanced Nursing Practice
The objective of this study was to determine whether routine preoperative type and screen blood testing is cost effective and medically warranted for benign diagnosis in healthy patients undergoing robotic hysterectomy. The study was designed as a cross sectional retrospective descriptive study. Four hundred and twenty-two medical records of American Society of Anesthesiologists (ASA) Classifications I and II patients undergoing robotically-assisted laparoscopic hysterectomy between 1 June 2011 and 31 May 2014 at a 211 bed regional medical center were analysed. The results from this study paralleled the findings of other published research. Preoperative type and screen testing was performed on 249 (59%) of the patients in the study. Ten patients (2.4% of the group) converted to open laparotomy. Mean estimated blood loss was 59.59ml. No perioperative transfusions were required. The results indicate that preoperative type and screen testing is not warranted for patients meeting the inclusion criteria.
Journal of Perioperative Practice
Rayborn, M. K.,
Turner, J. L.,
Park, S. G.
(2017). Cost Effectiveness of Preoperative Screening for Healthy Patients Undergoing Robotic Hysterectomy. Journal of Perioperative Practice, 27(6), 129-135.
Available at: https://aquila.usm.edu/fac_pubs/16640